文献速递脑血管病

急性缺血性卒中可逆性弥散加权成像病灶的系统综述

Reversible diffusion-weighted imaging lesions in acute ischemic stroke: A systematic review.
PubMed 文献 · Neurology · 2020-03-04

DWIR在基于DWI的研究中患病率为26.5%,在基于FLAIR/T2的研究中为6%,与再通或再灌注、早期神经功能改善及长期良好结局相关,提示DWI在卒中早期定义缺血核心存在局限性。

要点

  • DWIR患病率在DWI随访研究中为26.5%,在FLAIR/T2随访研究中为6%。
  • DWIR与再通或再灌注、早期t-PA治疗及较短血管内治疗时间相关。
  • DWIR与早期神经功能改善和长期良好结局相关,可能归因于再灌注。

核心结论

  • 可逆性弥散加权成像病灶见于高达四分之一的急性缺血性卒中患者,再灌注后与良好临床结局相关。
  • 研究结果凸显了DWI在卒中早期定义缺血核心的陷阱。

研究设计与样本

  • 提取临床、影像和结局数据。

主要发现

  • DWIR患病率在基于DWI的研究中为26.5%,在基于FLAIR/T2的研究中为6%。
  • DWIR与缺血组织再通或再灌注相关,无论是否使用t-PA或血管内治疗。
  • DWIR与较早的t-PA治疗、MRI后较短至血管内治疗时间以及DWI病灶内无或较轻灌注缺损相关。
  • DWIR与早期神经功能改善相关(6项研究中有5项)。
  • DWIR与长期结局相关(7项研究中有6项),可能归因于再灌注。

关键数值与推荐

  • 早期神经功能改善定义为NIHSS评分较基线改善4或8分,或治疗后24小时或出院时NIHSS评分0至2分,或第7天中位NIHSS评分。
  • 长期结局定义为NIHSS评分≤1分、NIHSS评分改善≥8分,或30或90天时改良Rankin量表评分≤2分。

临床怎么用

  • 在急性缺血性卒中早期,DWI病灶可能可逆,不应单独用于定义缺血核心。
  • 再灌注治疗与DWIR及良好结局相关,支持尽早实现再通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To systematically review the literature for reversible diffusion-weighted imaging (DWIR) lesions and to describe its prevalence, predictors, and clinical significance. METHODS: Studies were included if the first DWI MRI was performed within 24 hours of stroke onset and follow-up DWI or fluid-attenuated inversion recovery (FLAIR)/T2 was performed within 7 or 90 days, respectively, to measure DWIR. We abstracted clinical, imaging, and outcomes data. RESULTS: Twenty-three studies met the study criteria. The prevalence of DWIR was 26.5% in DWI-based studies and 6% in FLAIR/T2-based studies. DWIR was associated with recanalization or reperfusion of the ischemic tissue with or without the use of tissue plasminogen activator (t-PA) or endovascular therapy, earlier treatment with t-PA, shorter time to endovascular therapy after MRI, and absent or less severe perfusion deficit within the DWI lesion. DWIR was associated with early neurologic improvement in 5 of 6 studies (defined as improvement in the NIH Stroke Scale (NIHSS) score by 4 or 8 points from baseline or NIHSS score 0 to 2 at 24 hours after treatment or at discharge or median NIHSS score at 7 days) and long-term outcome in 6 of 7 studies (defined as NIHSS score ≤1, improvement in the NIHSS score ≥8 points, or modified Rankin Scale score up to ≤2 at 30 or 90 days) likely due to reperfusion. CONCLUSIONS: DWIR is seen in up to a quarter of patients with acute ischemic stroke, and it is associated with good clinical outcome following reperfusion. Our findings highlight the pitfalls of DWI to define ischemic core in the early hours of stroke.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Nagaraja N, Forder JR, Warach S, et al. Reversible diffusion-weighted imaging lesions in acute ischemic stroke: A systematic review. Neurology. 2020. PMID: 32132175. doi:10.1212/WNL.0000000000009173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。